China will provide among the strongest growth opportunities for pharmaceutical packaging based on rapidly expanding manufacturing capabilities and the upgrade of nationally produced medicines.
More generally, world pharmaceutical packaging demand is projected to increase 6.3 per cent annually to $62.3 billion in 2013.
The developed countries of Western Europe, the US and Japan will continue to account for more than 60 per cent of this amount.
Among other major developing economies, India and Brazil will also evolve into fast-growing pharmaceutical packaging markets as drugproducing sectors are upgraded and diversified, especially in the area of generic ethical drugs.
These and other trends are presented in World Pharmaceutical Packaging, a new study from The Freedonia Group, Inc, a Cleveland, US based industry research firm.
The US will remain the largest consumer of pharmaceutical packaging as its advanced drug-producing sector introduces new sophisticated therapies with specialised packaging needs.
Growth in West European demand will reflect upgraded government standards requiring unit dose, high barrier and anti-counterfeit packaging for many types of medication.
Based on its broad range of proprietary and generic drug producers, Japan will remain a large, diverse consumer of pharmaceutical containers, closures and related accessories.
World demand for primary pharmaceutical containers will increase 6.1 per cent annually through 2013 to $38.2 billion.
Prefillable inhalers and prefillable syringes will generate the fastest growth opportunities among all pharmaceutical packaging products based on performance advantages in drug delivery and the introduction of new bioengineered medicines.
Plastic bottles will sustain the largest share of global demand The Freedonia Group, Inc. Page 2 based on low cost, versatility, availability, and ongoing quality and design improvements.
Pharmaceutical blister packaging will generate favorable growth in global demand based on adaptability to unit dose, clinical trial, compliance, institutional and over-the-counter drugs.
Equipment upgrades, coupled with trends favoring unit dose packaging, will also boost demand for pouches and strip packs.
Parenteral vials and ampuls and, to a lesser extent, IV containers will fare well in the global marketplace as new injectable therapies based on biotechnology and other advanced disciplines reach the commercial stage.
By contrast, world demand for medication tubes and glass bottles and jars will expand at a below average pace due to competition from alternative containers.
Purchase the report
Add a comment